Thursday, July 3, 2025 7/3/2025

Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders

Award Number: R01DA051674
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2021
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders - The reproductive health needs of women with substance use disorders (SUDs) are unmet. Over 80% of pregnancies among women with SUDs are unintended, compared to 45% of the general population, and over 20% of women with SUDs have had a short interpregnancy interval (i.e. pregnancy within 18 months of a previous birth). Pregnancy is a unique opportunity to address contraceptive needs due to increased healthcare access from expanded Medicaid eligibility, increased access to highly effective contraceptive methods such as long-acting reversible contraception (LARC) and enhanced motivation to avoid rapid, repeat pregnancy. Despite this, over 75% of women with opioid use disorder fail to use postpartum contraception and less than 2% receive LARC in the postpartum period. Currently, there are no effective strategies to improve postpartum contraceptive decision-making for women with SUDs. To address this gap, we will conduct a hybrid type 1 effectiveness- implementation randomized controlled trial among 350 postpartum women with SUDs to test the effect of a novel patient-centered, reproductive planning decision support tool, developed by the research team, called MyPath on postpartum contraceptive method choice and continuation, continuous contraceptive use, unintended pregnancy and interpregnancy interval until 18 months postpartum. The primary research aims are to 1) assess the effect of patient-centered, reproductive planning decision support (MyPath) on postpartum contraceptive utilization and reproductive health outcomes among women with SUDs; 2) determine if the relationship between MyPath and contraceptive utilization is mediated by decision quality; and 3) identify barriers and facilitators to integrating MyPath into routine postpartum clinical care. This research is significant because using a patient-centered, reproductive planning approach to contraceptive decision-making represents a paradigm shift in both how we frame and approach reproductive health outcomes among women with SUDs. Our findings will have high impact if successful as decision support tools are a low-cost, scalable solution that can be used in most clinical settings and our study design enhances the potential for rapid translation of our findings into routine clinical practice. Finally, it is feasible because it builds on prior work by a research team with expertise in decision sciences, implementation, family planning, obstetrics and SUDs.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $623,229 )
2025	2025	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3240 CRAFT PL STE 100	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	000	5	4/10/2025	NON-COMPETING CONTINUATION	$623,229
														Subtotal = $623,229

Issue Date FY: 2024 ( Subtotal = $637,677 )
2024	2024	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3240 CRAFT PL STE 100	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	000	4	4/5/2024	NON-COMPETING CONTINUATION	$637,677
														Subtotal = $637,677

Issue Date FY: 2023 ( Subtotal = $630,489 )
2023	2023	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3339 WARD ST	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	001	3	4/6/2023	NON-COMPETING CONTINUATION	$630,489
2023	2022	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3339 WARD ST	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	000	2	11/30/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $630,489

Issue Date FY: 2022 ( Subtotal = $633,860 )
2022	2022	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3339 WARD ST	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	000	2	3/18/2022	NON-COMPETING CONTINUATION	$633,860
														Subtotal = $633,860

Issue Date FY: 2021 ( Subtotal = $713,607 )
2021	2021	MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION	3339 WARD ST	PITTSBURGH	PA	15213	ALLEGHENY	USA	Drug Use and Addiction Research Programs	000	1	5/21/2021	NEW	$713,607
														Subtotal = $713,607

Grand Total All Awards = $3,238,862

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders

Award Number: R01DA051674

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2021

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer